MedPath

Exploratory study on efficacy and safety of [11C]ketoprofen methylester in mild Alzheimer's disease, mild cognitive impairment and healthy volunteers.

Phase 2
Conditions
Alzheimer&#39
s disease Mild cognitive impairment
Registration Number
JPRN-UMIN000008674
Lead Sponsor
Division of Molecular Imaging, Institute of Biomedical Research and Innovation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

Peptic ulcer. Cerebrovascular disorder. Heart failure. Disease in blood, liver or kidney. Drug or food allergy. Possibility of pregnancy. MRI contraindication. Those judged by the investigator to be inappropriate as a participant of this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath